Quantcast

Latest Juvenile idiopathic arthritis Stories

2008-10-28 00:00:08

Bristol-Myers Squibb Company (NYSE: BMY) today announced at the American College of Rheumatology (ACR) Annual Scientific Meeting in San Francisco results from a 10-month study which showed that ORENCIA(R) (abatacept), compared to placebo, significantly improved multiple aspects of health-related quality of life (HRQoL): physical and psychosocial well being, pain and sleep quality in juvenile idiopathic arthritis (JIA) patients between the ages 6 and 17 years.

2008-10-25 21:00:11

NUTLEY, N.J., Oct. 25 /PRNewswire/ -- One-year data from a two-year Phase III study demonstrated that ACTEMRA(R) (tocilizumab) significantly inhibited the progression of structural joint damage in patients with rheumatoid arthritis (RA).

2008-09-18 12:00:11

NUTLEY, N.J., Sept. 18 /PRNewswire/ -- Roche today announced that the U.S.

2008-09-16 06:00:10

NORWALK, Conn., Sept. 16 /PRNewswire/ -- Arthritis afflicts half of Americans age 65 and older, according to the U.S. National Institutes of Health. Arthritis causes deterioration within the joints that serve as cushion between bones.

2008-08-28 03:00:19

By Taghdiri, Celia Many people are shocked to learn that arthritis isn't just "an old person's disease." The reality is about 300,000 U.S. children, or one in 250, have joint inflammation that causes pain, redness, heat and swelling. Juvenile arthritis occurs before age 16.

2008-08-19 00:00:11

Dr. George Still first described Still's Disease in 1897. It is a form of juvenile rheumatoid arthritis that has systemic features. Although it is more commonly found in children, the disorder can be present in adults, where it is known as Adult-Onset Still's Disease.

2008-07-29 15:00:28

NUTLEY, N.J., July 29 /PRNewswire/ -- Roche today announced that the Arthritis Advisory Committee of the U.S.